Home Nutromics

Nutromics

In operation
Series A
Molecular Monitoring Platform Developer

Basic Information

Nutromics is developing Continuous Molecular Monitoring (CMM) platform technology, which enables the tracking of multiple targets in the human body through a single wearable sensor. The platform provides real-time, continuous molecular-level insights for remote patient monitoring and home hospital systems.
Nutromics Pty, Ltd.
Victoria,Australia
15~50 people
January 01, 2017
info@nutromics.com.au